Favit A[au] - Search Results

Year	Number of Results
1988	1
1989	2
1991	2
1992	2
1993	3
1995	3
1996	1
1998	2
1999	2
2000	2
2003	1
2004	1
2007	2
2021	2
2022	1
2023	0

1

Adenosine A(2A) receptor antagonist treatment of Parkinson's disease.

Bara-Jimenez W, Sherzai A, Dimitrova T, Favit A, Bibbiani F, Gillespie M, Morris MJ, Mouradian MM, Chase TN. Bara-Jimenez W, et al. Among authors: favit a. Neurology. 2003 Aug 12;61(3):293-6. doi: 10.1212/01.wnl.0000073136.00548.d4. Neurology. 2003. PMID: 12913186 Clinical Trial.

2

Extended studies of the striatal uptake of 99mTc-NC100697 in healthy volunteers.

Koch W, Pogarell O, Pöpperl G, Hornung J, Hamann C, Gildehaus FJ, Seelos K, Lewis D, Favit A, Tatsch K. Koch W, et al. Among authors: favit a. J Nucl Med. 2007 Jan;48(1):27-34. J Nucl Med. 2007. PMID: 17204696 Free article. Clinical Trial.

3

Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label Treatment.

Hauser RA, Favit A, Hewitt LA, Lindsten A, Gorny S, Kymes S, Isaacson SH. Hauser RA, et al. Among authors: favit a. Neurol Ther. 2022 Mar;11(1):459-469. doi: 10.1007/s40120-021-00317-5. Epub 2022 Feb 2. Neurol Ther. 2022. PMID: 35107750 Free PMC article.

4

Droxidopa Persistence in Neurogenic Orthostatic Hypotension May Be Affected by Titration Approach.

Amjad F, Polenchar B, Favit A. Amjad F, et al. Among authors: favit a. Int J Gen Med. 2021 Aug 13;14:4485-4490. doi: 10.2147/IJGM.S304012. eCollection 2021. Int J Gen Med. 2021. PMID: 34421309 Free PMC article.

5

Calexcitin interaction with neuronal ryanodine receptors.

Nelson TJ, Zhao WQ, Yuan S, Favit A, Pozzo-Miller L, Alkon DL. Nelson TJ, et al. Among authors: favit a. Biochem J. 1999 Jul 15;341 ( Pt 2)(Pt 2):423-33. doi: 10.1042/0264-6021:3410423. Biochem J. 1999. PMID: 10393102 Free PMC article.

6

Alzheimer's-specific effects of soluble beta-amyloid on protein kinase C-alpha and -gamma degradation in human fibroblasts.

Favit A, Grimaldi M, Nelson TJ, Alkon DL. Favit A, et al. Proc Natl Acad Sci U S A. 1998 May 12;95(10):5562-7. doi: 10.1073/pnas.95.10.5562. Proc Natl Acad Sci U S A. 1998. PMID: 9576922 Free PMC article.

7

Characterization of the changes in supine blood pressure with long-term use of droxidopa in patients with neurogenic orthostatic hypotension.

Hewitt LA, Lindsten A, Gorny S, Karnik-Henry M, Kymes S, Favit A. Hewitt LA, et al. Among authors: favit a. Health Sci Rep. 2021 Jan 20;4(1):e227. doi: 10.1002/hsr2.227. eCollection 2021 Mar. Health Sci Rep. 2021. PMID: 33521332 Free PMC article.

8

Symptoms of sexual dysfunction in patients treated for major depressive disorder: a meta-analysis comparing selegiline transdermal system and placebo using a patient-rated scale.

Clayton AH, Campbell BJ, Favit A, Yang Y, Moonsammy G, Piontek CM, Amsterdam JD. Clayton AH, et al. Among authors: favit a. J Clin Psychiatry. 2007 Dec;68(12):1860-6. doi: 10.4088/jcp.v68n1205. J Clin Psychiatry. 2007. PMID: 18162016

9

Calexcitin: a signaling protein that binds calcium and GTP, inhibits potassium channels, and enhances membrane excitability.

Nelson TJ, Cavallaro S, Yi CL, McPhie D, Schreurs BG, Gusev PA, Favit A, Zohar O, Kim J, Beushausen S, Ascoli G, Olds J, Neve R, Alkon DL. Nelson TJ, et al. Among authors: favit a. Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13808-13. doi: 10.1073/pnas.93.24.13808. Proc Natl Acad Sci U S A. 1996. PMID: 8943017 Free PMC article.

10

cAMP-induced cytoskeleton rearrangement increases calcium transients through the enhancement of capacitative calcium entry.

Grimaldi M, Favit A, Alkon DL. Grimaldi M, et al. Among authors: favit a. J Biol Chem. 1999 Nov 19;274(47):33557-64. doi: 10.1074/jbc.274.47.33557. J Biol Chem. 1999. PMID: 10559242 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results